INDV Indivior Plc

Price (delayed)

$37.54

Market cap

$4.58B

P/E Ratio

18.68

Dividend/share

N/A

EPS

$2.01

Enterprise value

$4.91B

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 83

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline ...

Highlights
The net income has increased by 20% since the previous quarter
The EPS has grown by 20% from the previous quarter
The equity has grown by 49% YoY but it has contracted by 47% from the previous quarter
The quick ratio has grown by 18% from the previous quarter but it has contracted by 4.9% YoY
Indivior's debt has increased by 45% from the previous quarter and by 38% YoY

Key stats

What are the main financial stats of INDV

INDV stock price

How has the Indivior stock price performed over time
Intraday
5.96%
1 week
2.54%
1 month
-3.69%
1 year
174.62%
YTD
4.63%
QTD
23.16%

Financial performance

How have Indivior's revenue and profit performed over time
Revenue
$1.29B
Gross profit
$1.05B
Operating income
$333M
Net income
$251M
Gross margin
81.3%
Net margin
19.4%
The operating income is up by 27% since the previous quarter
INDV's operating margin is up by 22% since the previous quarter
The net income has increased by 20% since the previous quarter
Indivior's net margin has increased by 15% from the previous quarter

Price vs fundamentals

How does INDV's price correlate with its fundamentals

Growth

What is Indivior's growth rate over time

Valuation

What is Indivior stock price valuation
P/E
18.68
P/B
N/A
P/S
3.61
EV/EBIT
14.66
EV/EBITDA
13.87
EV/Sales
3.8
The EPS has grown by 20% from the previous quarter
INDV's price to earnings (P/E) is 9% lower than its last 4 quarters average of 19.3
The equity has grown by 49% YoY but it has contracted by 47% from the previous quarter
The stock's price to sales (P/S) is 26% more than its last 4 quarters average of 2.7
INDV's revenue is up by 10% year-on-year and by 4.2% since the previous quarter

Efficiency

How efficient is Indivior business performance
Indivior's ROA has increased by 24% from the previous quarter
The ROS has grown by 13% from the previous quarter
Indivior's return on invested capital has decreased by 8% QoQ

Dividends

What is INDV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for INDV.

Financial health

How did Indivior financials performed over time
Indivior's total assets is 11% lower than its total liabilities
The current ratio has grown by 21% from the previous quarter but it has contracted by 2.3% YoY
INDV's total liabilities is down by 19% year-on-year but it is up by 3.2% since the previous quarter
The debt to equity has dropped by 172% year-on-year
The equity has grown by 49% YoY but it has contracted by 47% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.